Harlan Krumholz

Medtronic Manipulated Bone Product Data, Senators Say

Medtronic Inc. ghost-wrote sections of medical papers and paid physician authors hundreds of millions of dollars in “consulting fees” to promote its bone- growth product Infuse, a U.S. Senate investigation found.

Medtronic to Release Infuse Data in Deal With Yale to Review Bone Studies

Medtronic Inc. said it will make the data on its embattled bone-growth product Infuse available to the public and pay for two independent analyses of the information in a move the company says may set a new industry standard.

Glaxo's Avandia Faces Potential Recall in U.S. Advisers' Vote

GlaxoSmithKline Plc’s Avandia may face tougher scrutiny from a U.S. advisory panel reviewing whether the diabetes pill should be pulled from the market than a similar analysis in 2007, doctors said.

Recall of Glaxo's Avandia Is One of Five Fates Considered by FDA Reviewers

GlaxoSmithKline Plc ’s study of its once best-selling diabetes pill Avandia doesn’t prove the drug is safe, according to U.S. regulators considering whether to recall it amid doctors’ concerns it causes heart complications.

Merck Drug Improves Cholesterol Without Safety Risk of Pfizer Pill

An experimental drug from Merck & Co. raised levels of good cholesterol, slashed bad cholesterol and may have helped patients avert heart complications, without the safety risks that prompted Pfizer Inc. to abandon a similar product four years ago.

Food Health Claims Need Scientific Tests, Report Says

General Mills Inc. ’s Cheerios are among the foods that should be held to the same scientific standards as pharmaceuticals when promoted as having health benefits, a report ordered by U.S. regulators said today.

Doctors Educated Outside U.S. Outperform Home-Grown Physicians

U.S. patients of doctors who went to medical school outside the country and weren’t American citizens had a 9 percent lower death rate on average than those whose doctors trained at home, a study showed.

"It's a historic agreement and one I hope will set a standard for everyone else in the industry."

- Harlan Krumholz on Aug 03, 2011

Food And Drug Administration

Yale University

Cleveland Clinic

Steven Nissen

Buffett Tells Coke CEO Study Failure, Avoid Complacency

Apple CEO Seeks to Stem Growth Concern by Returning Cash

Twitter Said to Bolster Security After AP Account Hacked

Deutsche Telekom Secures U.S. Position With MetroPCS Deal

Most U.S. Stocks Rise as Investors Weigh Earnings Reports